Annual report [Section 13 and 15(d), not S-K Item 405]

Shareholders' Equity (Details)

v3.25.0.1
Shareholders' Equity (Details)
12 Months Ended
Apr. 14, 2022
Dec. 31, 2024
vote
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Oct. 28, 2022
shares
Sep. 02, 2021
$ / shares
shares
Subsidiary, Sale of Stock [Line Items]          
Common stock authorized (in shares)   500,000,000 500,000,000   500,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001   $ 0.0001
Preferred stock authorized (in shares)   99,874,708 99,874,708   100,000,000
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001   $ 0.0001
Units outstanding (in shares)   67,002,370 65,546,174 63,852,690  
Number of votes held | vote   1      
Preferred stock outstanding (in shares)   0 0    
Committed equity facility          
Subsidiary, Sale of Stock [Line Items]          
Share purchase period 24 months